PATENT CLAIM ANALYSIS

Application Number: 16188652
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["514", "303000"]

Abstract:
The disclosure provides pharmaceutical compositions comprising Bach1 Inhibitors and Nrf2 Activators. The disclosure also provides methods of treating diseases such as psoriasis, multiple sclerosis, and COPD comprising administering a Bach1 Inhibitor and a Nrf2 Activator to a subject in need thereof.

Claim (Index 3):
The method of  claim 1 , wherein the Nrf2 activator is methyl 2-cyano-3,12-dioxooleana-1,9(11)dien-28-oate.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 98.0
- Lexical Diversity: 1.36364
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15584459', '16007532', '14215873', '13028406', '15718987']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7819693981576554
- 35 USC 102 Novelty (BERT): 0.6458302718034357
- Combined Prediction Score: 0.7683554855222335
- Mean Citation Score: 423.0322560000001
- Max Citation Score: 588.17633
- Similarity Product: 584.5891211068047

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test